• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil.

作者信息

Foulds G, O'Brien M M, Bianchine J R, Gabbay K H

出版信息

Clin Pharmacol Ther. 1981 Nov;30(5):693-700. doi: 10.1038/clpt.1981.222.

DOI:10.1038/clpt.1981.222
PMID:6794971
Abstract

Kinetics of sorbinil, an orally absorbed reductase inhibitor, were examined in man. Peak plasma concentrations were 0.95 micrograms/ml after a single 50-mg oral dose and 3.6 micrograms/ml after a 250-mg dose. The apparent volume of distribution was 840 ml/kg. Elimination from plasma was slow with a terminal half-life between 6 and 24 hr after dose of 34 to 52 hr and a renal clearance of 6.0 ml/min/1.73 m2. Administration of 50 mg/day for 5 days induced a mean peak serum concentration of 1.9 micrograms/ml. A dose of 250 mg/day for 10 days induced a peak serum concentration of 10.6 micrograms/ml. A mean of one-third of the dose was ultimately recovered unchanged in urine. Sorbinil kinetics make it suitable for once-a-day dosing.

摘要

相似文献

1
Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil.
Clin Pharmacol Ther. 1981 Nov;30(5):693-700. doi: 10.1038/clpt.1981.222.
2
Sorbinil pharmacokinetics in male and female elderly volunteers.
Br J Clin Pharmacol. 1987 Apr;23(4):495-7. doi: 10.1111/j.1365-2125.1987.tb03083.x.
3
Aldose reductase inhibitors and late complications of diabetes.醛糖还原酶抑制剂与糖尿病晚期并发症
Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010.
4
The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
Exp Eye Res. 1985 Jan;40(1):95-9. doi: 10.1016/0014-4835(85)90111-3.
5
Binding of an aldose reductase inhibitor to renal glomeruli.
Biochem Biophys Res Commun. 1985 Jun 14;129(2):530-5. doi: 10.1016/0006-291x(85)90184-6.
6
Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.阿雷司他汀和索比尼尔对人脑海藻糖还原酶和己糖酸脱氢酶的抑制作用。
J Neurochem. 1982 Sep;39(3):810-4. doi: 10.1111/j.1471-4159.1982.tb07964.x.
7
Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.醛糖还原酶抑制剂对人肾醛糖还原酶和醛脱氢酶的抑制动力学
Biochem Pharmacol. 1990 Mar 15;39(6):1115-24. doi: 10.1016/0006-2952(90)90292-s.
8
Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil.
J Med Chem. 1985 Nov;28(11):1716-20. doi: 10.1021/jm00149a030.
9
Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
J Med Chem. 1986 Nov;29(11):2384-9. doi: 10.1021/jm00161a040.
10
Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.用醛糖还原酶抑制剂索比尼尔预防半乳糖性白内障:一项光学显微镜研究。
Invest Ophthalmol Vis Sci. 1982 Feb;22(2):174-9.

引用本文的文献

1
Inhibition of Aldose Reductase by Novel Phytocompounds: A Heuristic Approach to Treating Diabetic Retinopathy.新型植物化合物对醛糖还原酶的抑制作用:一种治疗糖尿病视网膜病变的启发式方法。
Evid Based Complement Alternat Med. 2022 Mar 21;2022:9624118. doi: 10.1155/2022/9624118. eCollection 2022.
2
myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.糖尿病患者在服用索比尼尔治疗前后红细胞中的肌醇和山梨醇
Diabetologia. 1984 Nov;27(5):514-6. doi: 10.1007/BF00290386.
3
Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.
使用醛糖还原酶抑制剂索比尼尔对症状性糖尿病神经病变进行的临床和神经生理学研究。
Diabetologia. 1984 Jun;26(6):445-8. doi: 10.1007/BF00262218.
4
Activated and unactivated forms of human erythrocyte aldose reductase.人红细胞醛糖还原酶的活化形式与非活化形式。
Proc Natl Acad Sci U S A. 1985 Nov;82(21):7222-6. doi: 10.1073/pnas.82.21.7222.
5
Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.醛糖还原酶抑制剂治疗糖尿病性多发性神经病的益处有限:一项为期24周的对照试验。
Diabetologia. 1985 Jun;28(6):323-9. doi: 10.1007/BF00283137.
6
The effect of sorbinil treatment on red cell sorbitol levels and clinical and electrophysiological parameters of diabetic neuropathy.
J Neurol. 1986 Jun;233(3):174-7. doi: 10.1007/BF00314428.
7
Cerebral cortical capillary basement membrane thickening in galactosaemic rats.
Diabetologia. 1987 Sep;30(9):739-44. doi: 10.1007/BF00296999.
8
Sorbinil pharmacokinetics in male and female elderly volunteers.
Br J Clin Pharmacol. 1987 Apr;23(4):495-7. doi: 10.1111/j.1365-2125.1987.tb03083.x.
9
Aldose reductase inhibitors and late complications of diabetes.醛糖还原酶抑制剂与糖尿病晚期并发症
Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010.